ArticleACS medicinal chemistry letters2012

Inhibitors of LRRK2 as Treatment for Parkinson's Disease: Patent Highlight.

Ahmed F Abdel-MagidPubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.